Janssen concentrated his practice in pharmaceutical, medical device, and mass torts defense and risk containment. In practice, he was involved in various high-profile drug cases, including the national diet drug “fen-phen” litigations and DES litigations. Both as a practitioner and in academia, he has spoken and written frequently on pharmaceutical and medical device law.